Tokai Shareholders File Suit To Stop Otic Pharma Deal
A proposed class of Investors in Tokai Pharmaceuticals Inc. on Tuesday hit the drugmaker with a suit in Massachusetts federal court, alleging shortcomings in the proxy statement surrounding a deal in...To view the full article, register now.
Already a subscriber? Click here to view full article